AIMG’s 2025 value-chain analysis argues that the biggest returns in healthcare AI are accruing not to the flashiest models but to the firms that control data plumbing, embed inside EHR workflows and monetise operational fixes with hard ROI.
Nine stages, three profit pools
The industry breaks into nine linked stages—from data exchange and identity through cloud, MLOps and compliance, to integration middleware, apps, and distribution. The fattest value pools concentrate in Stage 5 (integration & middleware), Stage 7 (operational apps) and Stage 8 (administrative apps).
Go-to-market now decides winners
Distribution, not just product, is decisive. Epic’s marketplace routes and hyperscaler channels amplify reach, while Vizient and Premier shape provider purchasing. Electronic health record (EHR) partner programmes tend to use flat fees (not rev-share), and Group Purchasing Organizations (GPOs) typically keep ~45% of admin fees—small details that matter for vendor margins.
Economics are maturing
Ambient documentation pricing has compressed to ~$200 per clinician/month with some per-note add-ons—evidence of competition and buyer discipline. GPU access and inference costs remain practical constraints for model-heavy strategies.
Regulation is a design brief
Expect product roadmaps to be written to FDA PCCP and the EU AI Act. Assurance, monitoring and post-market evidence are no longer “nice-to-haves” but table stakes.
Who’s where on the chain (selected)
-
Data & identity: Epic, Health Gorilla, Particle Health, Zus Health.
-
Cloud & hosting: Microsoft Azure, AWS, GCP, Epic private MSPs.
-
Build & operate AI: Cognizant, Accenture, EPAM Systems.
Source: AI in Healthcare – Industry Value Chain Analysis and Strategic Roadmap 2025